 |
|
 
|
|
|
| Alkermes |
Enzytech |
$33,000,000 |
| Amersham International plc |
Pharmacia Biotech
(Joint Venture Formation) |
Undisclosed |
| ArQule |
Camitro |
$85,000,000 |
| Arris |
Khepri |
$22,000,000 |
| Autocyte Inc. |
NeoPath |
$96,000,000 |
| Bio Participations |
Becton, Dickinson and Company
( Sale of Equity Stake of BMH S.A.) |
Undisclosed |
| Bio-Technology General |
Gynex |
$52,185,000 |
| Centocor |
Tocor II |
$90,000,000 |
| Cephalon |
Cephalon Clinical Partners |
Undisclosed |
| Chiroscience |
Darwin Molecular |
$120,000,000 |
| Ciba-Geigy Ltd. |
Chiron Corporation |
$2,000,000,000 |
| Corixa |
Ribi Immunochem |
$58,500,000 |
| Gensia |
Aramed |
$38,000,000 |
| Genzyme |
Biosurface Technology |
Undisclosed |
| Genzyme |
Neozyme II |
$109,000,000 |
| Incyte |
Proteome |
$77,000,000 |
| Incyte |
Synteni |
$114,000,000 |
| Investor Group |
Roche
(Sale of Cedia Diagnostics Business) |
Undisclosed |
| Invitrogen |
Dexter and Life Technologies |
$1,900,000,000 |
| Johnson & Johnson |
DePuy |
$3,700,000,000 |
| Ligand |
ALRT formed with Allergan |
Undisclosed |
| Marmon Group |
BG Sulzle |
Undisclosed |
| Marquette Electronics |
American Home Products
(Divestiture of Corometrics) |
$74,000,000 |
| MDL |
Afferent Systems |
Undisclosed |
| Medchem |
C.R. Bard |
$102,000,000 |
| Nektar |
Aerogen |
$32,000,000 |
| Pacific Dunlop (Ansell Int'l Unit) |
Smith & Nephew plc
(Perry Glove Division) |
$55,000,000 |
| Pacific Dunlop Ltd. |
Johnson & Johnson Glove Business |
$98,000,000 |
| PerkinElmer, Inc. |
NEN Life Sciences |
$405,000,000 |
| Purdue Frederick |
CoCensys |
$9,500,000 |
| Smith & Nephew plc |
Acufex unit of American Home Products |
$141,000,000 |
| Smith & Nephew plc |
Advanced Tissue Sciences
(Joint Venture Formation) |
$70,000,000 |
| Solvay |
Unimed |
$123,000,000 |
| St. Jude Medical, Inc. |
Pacesetter Business of Siemens AG |
$500,000,000 |
| St. Jude Medical, Inc. |
Telectronics, Inc. |
$135,000,000 |
| St. Jude Medical, Inc. |
Ventritex, Inc. |
$363,000,000 |
| Structural Bioinformatics |
GeneFormatics |
Undisclosed |
| Sulzer Medica |
Spine-Tech |
$595,000,000 |
| UCB S.A. ( Belgium ) |
Whitby Pharmaceutical Subsidiary of Ethyl Corp.
(Divestiture of Subsidiary) |
$63,000,000 |
| |
|
|
| *Transactions completed by principals, including those completed at other firms. |
|
|
|
|
|
|
|
